ArticleDiscover oncology2023

Efficacy and safety of different PD-1 inhibitors in combination with lenvatinib in the treatment of unresectable primary liver cancer: a multicentre retrospective study.

Qi-Mei Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.